Yasuhara Chemical Co.,Ltd. (TYO:4957)
Japan · Delayed Price · Currency is JPY 1,369.00
0.00 (0.00%)
At close: Feb 6, 2026
Yasuhara Chemical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 |
|---|---|---|---|---|---|---|
Period Ending | Dec '10 Dec 31, 2010 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 | Mar '07 Mar 31, 2007 | Mar '06 Mar 31, 2006 |
| 11,427 | 10,560 | 10,255 | 11,197 | 11,358 | 10,717 | |
Revenue Growth (YoY) | 18.26% | 2.98% | -8.42% | -1.41% | 5.98% | 7.94% |
Cost of Revenue | 8,235 | 7,859 | 7,892 | 8,333 | 8,192 | 7,634 |
Gross Profit | 3,192 | 2,701 | 2,363 | 2,864 | 3,165 | 3,083 |
Selling, General & Admin | 1,499 | 1,379 | 1,512 | 1,571 | 1,638 | 1,560 |
Research & Development | 249.86 | 249.86 | 329.85 | 324.41 | 353.13 | 344.21 |
Operating Expenses | 1,903 | 1,783 | 2,079 | 2,165 | 2,169 | 2,038 |
Operating Income | 1,289 | 917.9 | 284.39 | 699.66 | 996.47 | 1,045 |
Interest Expense | -21.17 | -24.78 | -33.36 | -31.98 | -15.12 | -10 |
Interest & Investment Income | 12.31 | 11.74 | 20.78 | 19.62 | 24.17 | 13.24 |
Earnings From Equity Investments | - | - | - | 0.44 | 0.74 | - |
Currency Exchange Gain (Loss) | -42.78 | -8.59 | -90.89 | -52.48 | 15.97 | 73.03 |
Other Non Operating Income (Expenses) | 42.32 | 27.31 | 4.32 | 21.23 | 35.16 | 22.47 |
EBT Excluding Unusual Items | 1,279 | 923.59 | 185.25 | 656.48 | 1,057 | 1,143 |
Gain (Loss) on Sale of Investments | -6.46 | -6.46 | 1.16 | -20.08 | 76.07 | 8.23 |
Gain (Loss) on Sale of Assets | -21.37 | -2.35 | -13.01 | -0.46 | -2.45 | -18.91 |
Other Unusual Items | -5.1 | -79.1 | 51.87 | - | - | 0.3 |
Pretax Income | 1,246 | 835.68 | 235.55 | 635.94 | 1,131 | 1,133 |
Income Tax Expense | 502.85 | 337.69 | 77.11 | 240.53 | 448.94 | 461.72 |
Net Income | 743.55 | 498 | 158.43 | 395.42 | 682.06 | 671.3 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 19.8 |
Net Income to Common | 743.55 | 498 | 158.43 | 395.42 | 682.06 | 651.5 |
Net Income Growth | 101.71% | 214.33% | -59.93% | -42.03% | 1.60% | -2.00% |
Shares Outstanding (Basic) | 10 | 11 | 11 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 10 | 11 | 11 | 11 | 11 | 11 |
Shares Change (YoY) | -2.77% | -0.18% | -0.01% | -0.00% | -0.01% | -0.01% |
EPS (Basic) | 71.85 | 46.87 | 14.88 | 37.14 | 64.07 | 61.20 |
EPS (Diluted) | 71.85 | 46.87 | 14.88 | 37.14 | 64.07 | 61.20 |
EPS Growth | 107.45% | 214.90% | -59.93% | -42.02% | 4.70% | -4.88% |
Free Cash Flow | -130.39 | 1,107 | 810.89 | -609.64 | -1,464 | 510.02 |
Free Cash Flow Per Share | -12.60 | 104.16 | 76.18 | -57.27 | -137.50 | 47.91 |
Dividend Per Share | 12.000 | 12.000 | 12.000 | 12.000 | 12.000 | 12.000 |
Gross Margin | 27.93% | 25.58% | 23.04% | 25.58% | 27.87% | 28.77% |
Operating Margin | 11.28% | 8.69% | 2.77% | 6.25% | 8.77% | 9.75% |
Profit Margin | 6.51% | 4.72% | 1.54% | 3.53% | 6.00% | 6.08% |
Free Cash Flow Margin | -1.14% | 10.48% | 7.91% | -5.44% | -12.89% | 4.76% |
EBITDA | 1,944 | 1,611 | 1,159 | 1,510 | 1,542 | 1,597 |
EBITDA Margin | 17.01% | 15.25% | 11.30% | 13.49% | 13.57% | 14.90% |
D&A For EBITDA | 655.43 | 692.65 | 874.13 | 810.52 | 545.28 | 552.72 |
EBIT | 1,289 | 917.9 | 284.39 | 699.66 | 996.47 | 1,045 |
EBIT Margin | 11.28% | 8.69% | 2.77% | 6.25% | 8.77% | 9.75% |
Effective Tax Rate | 40.34% | 40.41% | 32.74% | 37.82% | 39.69% | 40.75% |
Revenue as Reported | 10,560 | 10,560 | 10,255 | 11,197 | 11,358 | 10,717 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.